Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,475.74
(
-0.06%
)
News Focus
News Focus
Post# of 257265
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 198146

Wednesday, 02/17/2016 10:54:08 AM

Wednesday, February 17, 2016 10:54:08 AM

Post# of 257265
NVS seeks SCOTUS ruling on 180-day notice period for FoBs:

http://www.law360.com/topnews/articles/759945/breaking-sandoz-seeks-high-court-take-on-biosimilar-law

NVS has a reasonable argument, IMO. If Congress intended the notice provision to confer an additional six months of marketing exclusivity for the reference branded drug, Congress could have simply added six months to the statutory 12-year exclusivity period in the BCPIA portion of the ObamaCare legislation.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today